THENATIONALPULSE (Pulse Wires) - ‘Hims’ Halts Semaglutide Pill One Day After The National Pulse’s Report.
PULSE POINTS WHAT HAPPENED: Hims announced it will stop offering access to its untested compounded semaglutide pill. WHO WAS INVOLVED: Hims and its woke CEO. WHEN & WHERE: The decision was made following a report by The National Pulse on Friday, February 6th. KEY QUOTE: “We’ve had constructive conversations with stakeholders across the industry.” – […] The post ‘Hims’ Halts Semaglutide Pill One Day After The National Pulse’s Report. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: Hims announced it will stop offering access to its untested compounded semaglutide pill. WHO WAS INVOLVED: Hims and its woke CEO. WHEN & WHERE: The decision was made following a report by The National Pulse on Friday, February 6th. KEY QUOTE: “We’ve had constructive conversations with stakeholders across the industry.” – Hims IMPACT: The company aims to continue providing safe, affordable, and personalized care to Americans. IN FULL Just one day after The National Pulse’s report on Hims, its woke CEO, and its unproven GLP-1 knockoff drugs, the company has announced it will stop offering access to its compounded semaglutide pill. The decision comes as Hims states that since launching the…Open